---
schema_version: "secwatch.filing_event.v1"
accession: "0000719135-23-000002"
form_type: "8-K"
ticker: "APYX"
cik: "0000719135"
company_name: "Apyx Medical Corp"
filed_at: "2023-01-10T23:59:59+00:00"
generated_at: "2026-06-20T17:20:20.255775+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Apyx Medical reports preliminary Q4 revenue $12.1-12.5M (-26-28% YoY); full year $44-44.4M (-8-9%)

## Summary
- Advanced Energy rev Q4 $10.1-10.5M (-30-33% YoY); OEM rev $2.0M (+12% YoY).
- Full year Advanced Energy $36.4-36.8M (-14-15%); OEM $7.6M (+37%).
- CEO cites continued disruption from FDA Medical Device Safety Communication.
- Expects 2023 Advanced Energy sales growth >35% YoY; plans to submit 510(k) for new indication by Jan 2023.
- Implementing expense cuts to improve cash flow; evaluating options for liquidity enhancement.

## SEC filing metadata
- accession: 0000719135-23-000002
- form_type: 8-K
- ticker: APYX
- cik: 0000719135
- company_name: Apyx Medical Corp
- filed_at: 2023-01-10T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/719135/000071913523000002/0000719135-23-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/719135/000071913523000002/apyx-20230110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000719135-23-000002
- JSON: https://secwatch.observer/filing/0000719135-23-000002.json
- Plain text: https://secwatch.observer/filing/0000719135-23-000002.txt

## Key facts
- Earnings Releases
  Apyx Medical Corp reported preliminary financial results for the quarter and year ended December 31, 2022.
  - Period: the quarter and year ended December 31, 2022
  - Result: preliminary results
  source text: On January 10, 2023, Apyx Medical Corporation (the "Company") issued a press release reporting on its preliminary revenue results for the quarter and year ended December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/719135/000071913523000002/0000719135-23-000002-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.